Canadian Hemochromatosis Society

What Canadian Hemochromatosis Society does

The Canadian Hemochromatosis Society (CHS) is a registered non-profit charitable society founded in 1980 by Marie Warder and headquartered in Vancouver, British Columbia, with a 1-10 employee footprint. The organization is the only national voluntary organization in Canada dedicated to hereditary hemochromatosis, a genetic iron-overload disorder affecting approximately 1 in 300 Canadians. CHS provides educational resources covering symptoms, diagnosis, genetic testing, and treatment (primarily therapeutic phlebotomy), supported by a network of local chapters across Canada and a bilingual (English/French) website at toomuchiron.ca.

The society's core offerings are information products and community programs rather than technology: an educational resource library, a community support program via volunteer chapters, an email newsletter, and an annual May Hemochromatosis Awareness Month campaign distributed through social media, radio ads, and media outreach. Recurring strategic partnerships with Canadian Blood Services (Partners for Life, Partner ID: CANA002257) and Héma-Québec enable hemochromatosis patients to fulfill therapeutic phlebotomy requirements through the national blood donation supply chain, integrating patient treatment with public blood supply.

CHS operates a donation-based revenue model with an annual membership subscription tier and tax receipts issued for donations of $20 or more (Charity No: 119219160 RR 0001). Its primary customer segments are individuals with hereditary hemochromatosis, their families, eligible patient-donors, and to a secondary degree, healthcare providers. The society does not charge for core services and has no disclosed enterprise customers, government contracts, or product commercialization.

Name

Canadian Hemochromatosis Society

Legal name

Canadian Hemochromatosis Society

Website

https://toomuchiron.ca

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

1–10 employees

Short description

The Canadian Hemochromatosis Society is a Canadian registered charity founded in 1980 that provides education, awareness, and community support for individuals and families affected by hereditary hemochromatosis, partnering with Canadian Blood Services and Héma-Québec to enable therapeutic phlebotomy through blood donation.

Ownership category

akta.pro rank

Product category

Hereditary Hemochromatosis Advocacy

NAICS

Voluntary Health Organizations (813212)

SIC

Services-Health Services (8000)

akta.pro industry

PRIMARYBPAGACAJ

Blood, Organ & Tissue Donation Organizations

Business & Public Services/Nonprofit, NGO & Social Services/Health & Medical Nonprofits

Keywords

• Hereditary hemochromatosis awareness
• Patient support services
• Genetic disorder education
• Community health advocacy
• Nonprofit health society

Headquarters

HQ city

Richmond

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Others

Revenue model

1. Donations: The society accepts charitable donations to support research, education, community outreach programs, awareness-raising projects, and advocacy efforts for hereditary hemochromatosis.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

The Canadian Hemochromatosis Society is a registered nonprofit charitable organization that delivers education, public awareness, and community support services for individuals and families affected by hereditary hemochromatosis in Canada. It disseminates information about the condition, symptoms, diagnosis, genetic testing, and treatment (therapeutic phlebotomy), and facilitates therapeutic blood donation through formal partnerships with Canadian Blood Services and Héma-Québec.

Product overview

The Canadian Hemochromatosis Society operates as a non-profit health organization offering educational resources and support services for individuals affected by hereditary hemochromatosis. The Society provides information about the genetic condition through its website, including detailed guides on symptoms, diagnosis, genetic testing, and treatment protocols (primarily therapeutic phlebotomy). Key offerings include community support through volunteer chapters, a newsletter for updates, an annual Awareness Month campaign in May with promotional materials, and partnerships with Canadian Blood Services and Héma-Québec enabling patients to use blood donation as treatment.

Differentiator

Problem solved

Functional benefit

Products and services

• Membership Program Annual subscription-based membership program for individuals, families, and supporters that adds their voice to advocacy efforts and supports the society's mission of making early diagnosis of hereditary hemochromatosis the rule rather than the exception.

Quantifiable outcome

• 1 in 300 Canadians affected by hemochromatosis can be diagnosed early with proper awareness and testing
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• Canadian Blood ServicescoreGTM or Marketing PartnerThe Canadian Hemochromatosis Society is a member of Canadian Blood Services' Partners for Life program (Partner ID: CANA002257). This partnership allows hemochromatosis patients to donate blood for therapeutic phlebotomy treatment at Canadian Blood Services locations and have their donations tracked and pooled with other hemochromatosis community members. This enables patients to receive their treatment in a more comfortable environment while contributing to Canada's blood supply.
• Héma-QuébeccoreGTM or Marketing PartnerPartnership with Héma-Québec to provide blood donation services for hemochromatosis patients in the province of Quebec. Patients can access therapeutic phlebotomy treatment through Héma-Québec's network of blood donation centers.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Emerging players

• Thalassemia Foundation of Canada: A Canadian patient-advocacy nonprofit for another hereditary blood disorder; comparable grassroots, donation-funded, chapter-based model serving a rare-condition population with similar awareness-raising needs.
• Aplastic Anemia & Myelodysplastic Association of Canada (AAMAC): A Canadian small nonprofit supporting patients with rare blood disorders through awareness, education, and community programs — comparable patient-advocacy nonprofit model with overlapping chapter/membership structure but different disease focus.
• Canadian Hemophilia Society: A Canadian national voluntary health organization for another inherited blood/bleeding disorder; analogous donation-funded patient-advocacy model and similar partnership patterns with Canadian Blood Services.

Direct peers

• Iron Disorders Institute (now part of the Iron Disorders Collective): A U.S. nonprofit historically dedicated to education and information on iron-overload disorders including hemochromatosis; directly comparable mission and educational-resource product set.
• American Hemochromatosis Society: The American Hemochromatosis Society is a U.S. nonprofit patient-advocacy organization focused exclusively on hereditary hemochromatosis awareness, education, and support — a direct U.S. analogue of the Canadian Hemochromatosis Society with the same mission, donor-funded model, and blood-donation linkage strategy.

Others

• Canadian Organization for Rare Disorders (CORD): A Canadian umbrella nonprofit advocating for patients with rare diseases (including hemochromatosis); not a direct competitor but a potential ally and donor/funder relationship for CHS's advocacy work.

Regional players

• Haemochromatosis Society (UK) - now Haemochromatosis International affiliate: A UK-based voluntary organization serving hereditary hemochromatosis patients across the UK; same disease-area focus, comparable donor-funded advocacy model, but operating in a different geography than CHS.

Broad incumbents

• Canadian Liver Foundation: A much larger Canadian nonprofit covering liver diseases broadly, including hemochromatosis-related cirrhosis as a complication; a broader incumbent with overlapping patient constituencies and donor pools but not specialized in hemochromatosis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/TooMuchIron
• LinkedInlinkedin.com/company/canadian-hemochromatosis-society
• Instagraminstagram.com/canadianhemochromatosissociety
• Xx.com/ironoutcanada

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canadian Hemochromatosis Society